RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Dutch consumers can eat healthier and more environmentally sustainable for the same amount of money The Dutch diet can be healthier and more environmentally sustainable without costing consumers more money. This holds for all socio-economic groups in the Netherlands. This concludes Reina Vellinga (RIVM) in her doctoral thesis. Even with minor adjustments, our diet becomes much healthier and with less impact on the environment.
Number of tuberculosis patients in the Netherlands increased in 2023 compared to 2022 In 2023, 710 people in the Netherlands were diagnosed with tuberculosis (TB). This was 12 per cent more than in 2022, when there were 634. In 2023, 471 patients had pulmonary TB. Of these 417 patients, 213 had open TB – the most contagious type.
Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.